Germany reviews its policy on HPV vaccination for 12-17 year oldsBMJ 2009; 338 doi: https://doi.org/10.1136/bmj.b1692 (Published 27 April 2009) Cite this as: BMJ 2009;338:b1692
- Ned Stafford
Germany’s Robert Koch Institute is reviewing its recommendation that all 12-17 year old girls should be vaccinated against the human papillomavirus (HPV) to reduce the risk of cervical cancer, after criticism from experts.
A group of 13 medical scientists publicly criticised the institute’s recommendation in November 2008 (Sueddeutsche Zeitung, 26 Nov).
Susanne Glasmacher, spokeswoman at the Berlin based institute, which is responsible for disease control and prevention in Germany, told the BMJ that the institute’s standing vaccination committee was undertaking the review because new studies had been published and because of the “public discussion” generated by the 13 scientists.
However, she hinted that the committee would not reverse the original …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial